Effect of diltiazem on norepinephrine-induced acute left ventricular dysfunction

Area of Science:

• Cardiology
• Pharmacology
• Toxicology

Background:

• Norepinephrine can cause cardiotoxicity, leading to impaired left ventricular function.
• Understanding protective agents against drug-induced cardiac damage is crucial for clinical applications.
• Canine models provide valuable insights into cardiovascular responses to toxic agents.

Purpose of the Study:

• To investigate the protective role of diltiazem against norepinephrine-induced cardiotoxicity in a canine model.
• To assess the impact of diltiazem on left ventricular function and hemodynamics following norepinephrine exposure.

Main Methods:

• Anesthetized dogs underwent norepinephrine infusion (4 µg/kg/min for 90 min) or saline control.
• Diltiazem (20 µg/kg/min x 5 min pretreatment, then 10 µg/kg/min x 90 min) or saline was administered.
• Left ventricular function was evaluated using radionuclide angiography and echocardiography; hemodynamic parameters were monitored.

Main Results:

• Saline-treated dogs showed hypotension, increased heart rate, and significantly reduced ejection fraction post-norepinephrine.
• Diltiazem-treated dogs maintained stable hemodynamics and preserved left ventricular ejection fraction.
• Norepinephrine increased left ventricular end-systolic wall stress in saline controls but not in diltiazem-treated dogs.

Conclusions:

• Norepinephrine cardiotoxicity in this model is associated with increased afterload and left ventricular wall stress.
• Diltiazem pretreatment significantly protected left ventricular function against norepinephrine-induced damage.
• Diltiazem demonstrates potential as a cardioprotective agent in managing norepinephrine-related toxicity.